vs
PATTERSON UTI ENERGY INC（PTEN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
PATTERSON UTI ENERGY INC的季度营收约是Royalty Pharma plc的1.8倍（$1.1B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -2.2%，领先36.6%），Royalty Pharma plc同比增速更快（4.8% vs -12.7%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -8.4%）
帕特森UTI能源是领先的油田服务供应商，主营陆上合同钻井、压力泵送、完井及相关配套服务，核心市场覆盖北美地区，主要服务上游油气开采企业，业务聚焦页岩气、致密气等非常规资源开发领域。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PTEN vs RPRX — 直观对比
营收规模更大
PTEN
是对方的1.8倍
$622.0M
营收增速更快
RPRX
高出17.5%
-12.7%
净利率更高
RPRX
高出36.6%
-2.2%
两年增速更快
RPRX
近两年复合增速
-8.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $622.0M |
| 净利润 | $-24.5M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | -2.2% | 34.4% |
| 营收同比 | -12.7% | 4.8% |
| 净利润同比 | -170.8% | 2.9% |
| 每股收益（稀释后） | $-0.06 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PTENRPRX
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $622.0M | ||
| Q3 25 | $1.2B | $609.3M | ||
| Q2 25 | $1.2B | $578.7M | ||
| Q1 25 | $1.3B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.3B | $564.7M | ||
| Q2 24 | $1.3B | $537.3M |
净利润PTENRPRX
| Q1 26 | $-24.5M | — | ||
| Q4 25 | $-9.2M | $214.2M | ||
| Q3 25 | $-36.4M | $288.2M | ||
| Q2 25 | $-49.1M | $30.2M | ||
| Q1 25 | $1.0M | $238.3M | ||
| Q4 24 | $-51.4M | $208.2M | ||
| Q3 24 | $-978.8M | $544.0M | ||
| Q2 24 | $11.1M | $102.0M |
营业利润率PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | -0.0% | 62.4% | ||
| Q3 25 | -2.4% | 70.1% | ||
| Q2 25 | -2.4% | 36.3% | ||
| Q1 25 | 1.3% | 94.0% | ||
| Q4 24 | -2.7% | 60.9% | ||
| Q3 24 | -73.8% | — | ||
| Q2 24 | 3.4% | 50.2% |
净利率PTENRPRX
| Q1 26 | -2.2% | — | ||
| Q4 25 | -0.8% | 34.4% | ||
| Q3 25 | -3.1% | 47.3% | ||
| Q2 25 | -4.1% | 5.2% | ||
| Q1 25 | 0.1% | 41.9% | ||
| Q4 24 | -4.5% | 35.1% | ||
| Q3 24 | -72.9% | 96.3% | ||
| Q2 24 | 0.8% | 19.0% |
每股收益（稀释后）PTENRPRX
| Q1 26 | $-0.06 | — | ||
| Q4 25 | $-0.01 | $0.49 | ||
| Q3 25 | $-0.10 | $0.67 | ||
| Q2 25 | $-0.13 | $0.07 | ||
| Q1 25 | $0.00 | $0.55 | ||
| Q4 24 | $-0.10 | $0.46 | ||
| Q3 24 | $-2.50 | $1.21 | ||
| Q2 24 | $0.03 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $3.2B | $9.7B |
| 总资产 | $5.4B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | $418.5M | $618.7M | ||
| Q3 25 | $184.8M | $938.9M | ||
| Q2 25 | $183.8M | $631.9M | ||
| Q1 25 | $223.1M | $1.1B | ||
| Q4 24 | $239.2M | $929.0M | ||
| Q3 24 | $113.4M | $950.1M | ||
| Q2 24 | $72.4M | $1.8B |
总债务PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $9.0B | ||
| Q3 25 | $1.2B | $8.9B | ||
| Q2 25 | $1.2B | $8.0B | ||
| Q1 25 | $1.2B | $7.6B | ||
| Q4 24 | $1.2B | $7.6B | ||
| Q3 24 | $1.2B | $7.6B | ||
| Q2 24 | $1.2B | $7.6B |
股东权益PTENRPRX
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $9.7B | ||
| Q3 25 | $3.2B | $9.6B | ||
| Q2 25 | $3.3B | $9.5B | ||
| Q1 25 | $3.4B | $9.8B | ||
| Q4 24 | $3.5B | $10.3B | ||
| Q3 24 | $3.6B | $10.3B | ||
| Q2 24 | $4.6B | $9.8B |
总资产PTENRPRX
| Q1 26 | $5.4B | — | ||
| Q4 25 | $5.6B | $19.6B | ||
| Q3 25 | $5.5B | $19.3B | ||
| Q2 25 | $5.6B | $18.3B | ||
| Q1 25 | $5.8B | $17.6B | ||
| Q4 24 | $5.8B | $18.2B | ||
| Q3 24 | $6.0B | $18.0B | ||
| Q2 24 | $7.0B | $17.7B |
负债/权益比PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | 0.38× | 0.92× | ||
| Q3 25 | 0.38× | 0.93× | ||
| Q2 25 | 0.37× | 0.84× | ||
| Q1 25 | 0.36× | 0.78× | ||
| Q4 24 | 0.36× | 0.74× | ||
| Q3 24 | 0.35× | 0.74× | ||
| Q2 24 | 0.27× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 4.9% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流PTENRPRX
| Q1 26 | $63.9M | — | ||
| Q4 25 | $397.5M | $827.1M | ||
| Q3 25 | $215.8M | $702.6M | ||
| Q2 25 | $139.7M | $364.0M | ||
| Q1 25 | $208.1M | $596.1M | ||
| Q4 24 | $315.8M | $742.5M | ||
| Q3 24 | $296.3M | $703.6M | ||
| Q2 24 | $197.5M | $658.2M |
自由现金流PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | $259.0M | — | ||
| Q3 25 | $71.3M | — | ||
| Q2 25 | $-4.5M | — | ||
| Q1 25 | $46.3M | — | ||
| Q4 24 | $175.5M | — | ||
| Q3 24 | $115.7M | — | ||
| Q2 24 | $67.0M | — |
自由现金流率PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | 22.6% | — | ||
| Q3 25 | 6.1% | — | ||
| Q2 25 | -0.4% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 15.3% | — | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 5.0% | — |
资本支出强度PTENRPRX
| Q1 26 | 4.9% | — | ||
| Q4 25 | 12.1% | — | ||
| Q3 25 | 12.3% | — | ||
| Q2 25 | 11.9% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 9.8% | — |
现金转化率PTENRPRX
| Q1 26 | — | — | ||
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 207.11× | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 17.83× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PTEN
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
